Voyage Medical raises $22M for heart treatment
Voyage Medical, which is developing new treatment for a heart condition called atrial fibrillation, has raised $22 million in a second round of financing. New investor Three Arch Partners led the round, with participation from Kleiner Perkins Caulfield & Byers (also a new investor) and existing investor RWI Ventures, according to VentureWire.
Atrial fibrillation is a heart abnormality that affects 2.2 million Americans. Three Arch partner Bill Harrington told VentureWire that Voyage Medical’s technique will improve on existing treatments because it allows doctors to perform “radiofrequency ablation” under direct visualization.
The Campbell, Calif. company previously raised $3.3 million in 2006.
Next Story: Just a touchpad and a screen: A grand unified theory of Apple’s next big move
Previous Story: Verizon shows you Visual Voice Mail — if you show them the money
About the Author, Anthony Ha
Anthony is VentureBeat's assistant editor, as well as its reporter on enterprise technology, cloud computing, and tech policy. Before joining VentureBeat in 2008, Anthony worked at the Hollister Free Lance, where he won awards from the California Newspaper Publishers Association for breaking news coverage and writing. He attended Stanford University and now lives in San Francisco. Reach him at anthony@venturebeat.com. You can also follow Anthony on Twitter.